Literature DB >> 16758365

M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.

Enrique Sánchez-Lemus1, José-Antonio Arias-Montaño.   

Abstract

In rat striatal slices labelled with [(3)H]-adenine and in the presence of 1 mM 3-isobutyl-1-methylxantine (IBMX), cyclic [(3)H]-AMP ([(3)H]-cAMP) accumulation induced by the dopamine D(1) receptor agonist SKF-81297 (1 microM; 177 +/- 13% of basal) was inhibited by the general muscarinic agonist carbachol (maximum inhibition 72 +/- 3%, IC(50) 0.30 +/- 0.06 microM). The muscarinic toxin 7 (MT-7), a selective antagonist at muscarinic M(1) receptors, reduced the effect of SKF-81297 by 40+/-7% (IC(50) 251+/- 57 pM) and enhanced the inhibitory action of a submaximal (1 microM) concentration of carbachol (69 +/- 4% vs. 40 +/- 7% inhibition, IC(50) 386 +/- 105 pM). The toxin MT-1, agonist at M(1) receptors, stimulated [(3)H]-cAMP accumulation in a modest but significant manner (137 +/- 11% of basal at 400 nM), an action additive to that of D(1) receptor activation and blocked by MT-7 (10 nM). The effects of MT-7 on D(1) receptor-induced [(3)H]-cAMP accumulation and the carbachol inhibition were mimicked by the PKC inhibitors Ro-318220 (200 nM) and Gö-6976 (200 nM). Taken together our results indicate that in addition to the inhibitory role of M(4) receptors, in rat striatum acetylcholine stimulates cAMP formation through the activation of M(1 )receptors and PKC stimulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758365     DOI: 10.1007/s11064-006-9052-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons.

Authors:  Z Yan; J Flores-Hernandez; D J Surmeier
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Medical management of Parkinson's disease.

Authors:  C E Clarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-03       Impact factor: 10.154

Review 3.  Studies of muscarinic neurotransmission with antimuscarinic toxins.

Authors:  Lincoln T Potter; Donna D Flynn; Jing-Sheng Liang; Mark H McCollum
Journal:  Prog Brain Res       Date:  2004       Impact factor: 2.453

4.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

Review 5.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

6.  Muscarinic M1 and M3 receptors in rat striatum: a binding study.

Authors:  M T de la Vega; A Nuñez; J A Arias-Montaño
Journal:  Arch Med Res       Date:  1997       Impact factor: 2.235

7.  Muscarinic receptor-mediated increase in cAMP levels in SK-N-SH human neuroblastoma cells.

Authors:  J Baumgold; P H Fishman
Journal:  Biochem Biophys Res Commun       Date:  1988-08-15       Impact factor: 3.575

8.  Selective expression of one Ca(2+)-inhibitable adenylyl cyclase in dopaminergically innervated rat brain regions.

Authors:  N Mons; D M Cooper
Journal:  Brain Res Mol Brain Res       Date:  1994-03

9.  Differential regulation of cAMP-mediated gene transcription by m1 and m4 muscarinic acetylcholine receptors. Preferential coupling of m4 receptors to Gi alpha-2.

Authors:  J C Migeon; N M Nathanson
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

Review 10.  Involvement of basal ganglia transmitter systems in movement initiation.

Authors:  W Hauber
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

View more
  9 in total

1.  Differential involvement of M1-type and M4-type muscarinic cholinergic receptors in the dorsomedial striatum in task switching.

Authors:  Martha F McCool; Sima Patel; Ravi Talati; Michael E Ragozzino
Journal:  Neurobiol Learn Mem       Date:  2007-08-20       Impact factor: 2.877

2.  CaMKIIalpha interacts with M4 muscarinic receptors to control receptor and psychomotor function.

Authors:  Ming-Lei Guo; Eugene E Fibuch; Xian-Yu Liu; Eun Sang Choe; Shilpa Buch; Li-Min Mao; John Q Wang
Journal:  EMBO J       Date:  2010-05-11       Impact factor: 11.598

Review 3.  Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders.

Authors:  Mark S Moehle; P Jeffrey Conn
Journal:  Mov Disord       Date:  2019-06-18       Impact factor: 10.338

4.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

5.  Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor.

Authors:  Mark S Moehle; Tristano Pancani; Nellie Byun; Samantha E Yohn; George H Wilson; Johnathan W Dickerson; Daniel H Remke; Zixiu Xiang; Colleen M Niswender; Jürgen Wess; Carrie K Jones; Craig W Lindsley; Jerri M Rook; P Jeffrey Conn
Journal:  Neuron       Date:  2017-12-20       Impact factor: 17.173

6.  Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats.

Authors:  Ashley E Brady; Carrie K Jones; Thomas M Bridges; J Phillip Kennedy; Analisa D Thompson; Justin U Heiman; Micah L Breininger; Patrick R Gentry; Huiyong Yin; Satyawan B Jadhav; Jana K Shirey; P Jeffrey Conn; Craig W Lindsley
Journal:  J Pharmacol Exp Ther       Date:  2008-09-04       Impact factor: 4.030

7.  Muscarinic inhibition of hippocampal and striatal adenylyl cyclase is mainly due to the M(4) receptor.

Authors:  Gonzalo Sánchez; Natalia Colettis; Pablo Vázquez; Carlos Cerveñansky; Alejandra Aguirre; Jorge A Quillfeldt; Diana Jerusalinsky; Edgar Kornisiuk
Journal:  Neurochem Res       Date:  2009-02-04       Impact factor: 3.996

8.  Suppression of IL-8 production from airway cells by tiotropium bromide in vitro.

Authors:  Isao Suzaki; Kazuhito Asano; Yusuke Shikama; Taisuke Hamasaki; Ayako Kanei; Harumi Suzaki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-09-06

9.  Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system.

Authors:  Alessandro Tozzi; Antonio de Iure; Michela Tantucci; Valentina Durante; Ana Quiroga-Varela; Carmela Giampà; Michela Di Mauro; Petra Mazzocchetti; Cinzia Costa; Massimiliano Di Filippo; Silvarosa Grassi; Vito Enrico Pettorossi; Paolo Calabresi
Journal:  Front Cell Neurosci       Date:  2015-05-27       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.